Evidence map›Paper›PMID 40808396›Full record

ArticleNeural regeneration research2026

Therapeutic mechanisms of umbilical cord mesenchymal stem cell-derived exosomes in ischemic stroke: A transcriptomic and metabolomic study.

Baoxi Shen, Jing Chen, Ning Liu, Jingyi Hou, Yiwu Dai

Abstract read
In one paragraph

Article in Neural regeneration research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Baoxi ShenMedical School of Chinese PLA, Beijing, China.
Jing ChenPhysical Examination Center, The People's Hospital of Pizhou, Xuzhou, Jiangsu Province, China.
Ning LiuDepartment of Neurosurgery, the Seventh Medical Center, Chinese PLA General Hospital, Beijing, China.
Jingyi HouBeijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
Yiwu DaiDepartment of Neurosurgery, the First Medical Centre, Chinese PLA General Hospital, Beijing, China.ORCID 0009-0000-3635-604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

JOURNAL/nrgr/04.03/01300535-202606000-00078/figure1/v/2026-02-11T151048Z/r/image-tiff Ischemic stroke remains a leading cause of disability and death, with mesenchymal stem cell-derived exosomes emerging as a promising therapeutic avenue. However, the optimal timing and underlying therapeutic mechanisms of exosome treatment require further elucidation. In this study, we used a murine model of middle cerebral artery occlusion to investigate the therapeutic efficacy of human umbilical cord mesenchymal stem cell-derived exosomes administered intravenously at an early (6 hours) or delayed (3 days) time point post-ischemia. Compared with delayed treatment, early administration of exosomes resulted in significantly superior efficacy, as evidenced by improved neurological function scores and reduced infarct volumes. Transcriptomic analysis of brain tissues from mice receiving early exosome treatment revealed marked downregulation of inflammation-related genes, including Ccl2 , Ccl5 , Cxcl10 , Il-1 β, Il-6 , Itgam , Itgax , and Tnf-α . Metabolomic profiling of these brain tissues further identified modulation of key metabolites, including trimethylamine N-oxide, glutathione, 1-stearoyl-rac-glycerol, and phosphatidylcholine, suggesting that alteration of metabolic pathways contributes to the therapeutic effect. Integrated transcriptomic and metabolomic analysis pinpointed significant modulation of pathways involving metabolism of eicosapentaenoic acid, lysine, propanoate, and tyrosine. These findings suggest that umbilical cord mesenchymal stem cell-derived exosomes, particularly when administered early post-ischemia, exert their neuroprotective effects by broadly suppressing inflammatory pathways and modulating key metabolic processes in the ischemic brain, highlighting their potential as a therapeutic intervention for ischemic stroke.

Indexed as

exosomesischemic strokemesenchymal stem cellsmetabolomicsmiddle cerebral artery occlusionstroketranscriptomics

Identifiers

PMID40808396
PMCPMC13211819

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.